MMP2 and chronic kidney disease: In this study, significant differences in concentration of TIMP-2 between CKD patients and controls and in metalloproteinase inhibitors TIMP-1 and TIMP-2 and the MMP-2/TIMP-2 ratio between CKD subjects in various stages were observed.